Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Maker TV Ads To Get Greater Chinese Scrutiny

This article was originally published in PharmAsia News

Executive Summary

Pharmaceutical advertisements are about to come under increased vigilance by the Chinese government as it tries to rid television of vulgar and sex-explicit content. The State Administration of Radio, Film and Television plans to tighten controls on exaggerations in advertisements involving the efficacy of drugs along with its other complaints. An SARFT official said some drug advertisements are changed between the time they are licensed by the government and the time they air, misleading consumers while breaking the law. The crackdown plans include added monitoring of ads for their "negative social impact." (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel